Form 4: Roivant Sciences CEO Sells Shares
Statement of Changes in Beneficial Ownership
Roivant Sciences CEO Matthew Gline reported a transaction involving the net settlement of Restricted Stock Units (RSUs) to cover tax obligations.
Summary
- Matthew Gline, CEO of Roivant Sciences, engaged in a transaction on June 30, 2026.
- This transaction involved the net settlement of 76,171 Restricted Stock Units (RSUs) to satisfy tax withholding obligations.
- The reported value of the transaction was $35.39 per share.
- Following this transaction, Gline beneficially owns 16,659,945 common shares directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard administrative transaction for tax purposes rather than a strategic investment or divestment decision.
Future Outlook
No specific future outlook or guidance is provided in this filing, as it pertains to a past transaction.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company executives and directors. This specific filing details a common practice of settling RSUs to cover tax liabilities upon vesting.
Stakeholder Impact
- Shareholders: Increased transparency regarding executive share ownership and common compensation settlement practices.
Key Dates
| Date | Description |
|---|---|
| 06/30/2026 | Earliest transaction date and transaction date for RSU settlement. |
| 07/02/2026 | Date of signature for the filing. |
Keywords
Form 4, SEC Filing, Roivant Sciences, Matthew Gline, RSU Settlement, Tax Withholding, Insider Transaction, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.